Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Supreme Court Rules for Roundup Manufacturer in Cancer Case

The Supreme Court sided with the herbicide manufacturer in a case brought by a Missouri man who attributed his cancer to Roundup exposure. The ruling is expected to impact thousands of similar cases across the country.

07/18/2026 · Wisconsin edition

Advertisement

Advertisement

Why it matters locally: The Supreme Court's decision limiting lawsuits against the manufacturer of Roundup could impact agricultural businesses and individuals across Wisconsin, as the herbicide is widely used by farmers and homeowners in the state. This ruling may make it more difficult for Wisconsin residents to pursue similar claims regarding health effects from glyphosate exposure.

The Supreme Court voted 7-2 to overturn a jury award in a case where a Missouri man claimed that exposure to Roundup caused his cancer. The decision favored the herbicide's manufacturer and is expected to affect the viability of thousands of pending lawsuits filed in courts nationwide. The jury had previously awarded the plaintiff compensation. The Supreme Court's majority opinion reversed that judgment, altering the legal standards that govern such claims. Dr. Chadi Nabhan, who authored a book examining the Monsanto trials and litigation over the herbicide, discussed the ruling's implications. Nabhan has written extensively on the legal battles surrounding Roundup exposure claims. Scientific research on the herbicide's health effects has produced conflicting findings. The International Agency for Research on Cancer classified glyphosate, Roundup's active ingredient, as probably carcinogenic in 2015. The U.S. Environmental Protection Agency reached a different conclusion in 2020, stating the chemical was unlikely to pose a cancer risk to humans at the exposure levels Americans typically encounter. Farmers, landscapers and homeowners have used Roundup for decades as a broad-spectrum herbicide. The product became one of the world's most widely used agricultural chemicals after its introduction in the 1970s. Plaintiffs in the litigation attributed their cancers to occupational or residential contact with the herbicide. They sought compensation from the manufacturer based on allegations that the company failed to adequately warn consumers about potential health risks. The court's decision removes a major avenue for additional lawsuits to proceed. Legal experts said the ruling sets a precedent that will make it substantially harder for future plaintiffs to bring similar cases to trial.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104108 articles8,220,515 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Wisconsin

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Wisconsin

health

Cost of GLP-1 Medications Prompts Search for Alternatives

Many Americans face financial hurdles when trying to access GLP-1 medications. These cost barriers have prompted some patients to seek out alternative, unregulated versions. The situation highlights ongoing challenges in prescription drug affordability.

Read Story →
health

Medicare for All Becomes Midterm Campaign Focus Amid Voter Support

Candidates in midterm elections are increasingly discussing 'Medicare for All.' A recent poll shows two-thirds of Americans support the concept. This reflects a public desire for significant changes in health care.

Read Story →
health

Flu Activity Increases Earlier This Season

Flu season typically begins in October or November. However, reports indicate an increase in influenza activity starting in September this year. This earlier onset prompts consideration of vaccination.

Read Story →
health

Supreme Court Begins Term with Key Arguments, Denies Hundreds of Cases

The Supreme Court began its new term by hearing arguments in two cases on Monday, focusing on climate change liability and veterans' benefits. The court also denied review in hundreds of cases, including disputes over student speech and COVID-19 vaccine mandates. Future arguments will address retirement fund management and federal environmental laws.

Read Story →
health

GLP-1 Medications See Increased Use, Spur Research into New Applications

GLP-1 medications are now used by an estimated one in eight Americans. Researchers continue to investigate new potential applications for these drugs. The expansion in use prompts further questions and research.

Read Story →
health

Bipartisan Concern Grows Over Pharmacy Benefit Managers

Republicans and Democrats alike are directing scrutiny toward pharmacy benefit managers, or PBMs. Tennessee and Arkansas have already implemented regulations targeting these healthcare companies. This convergence of political and public opinion highlights increasing pressure on PBM operations.

Read Story →
Scroll for more stories